| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/23/2009 | US20090186914 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 07/23/2009 | US20090186906 N-((S)-4,4-dimethyl-1-oxo-1-((3aS,6aR)-3-oxo-dihydro-2H-furo[3,2-b]pyrrol-4(5H6H, 6aH)-yl)pentan-2-yl)-4-(4-methylpiperazin-1-yl)benzamide; treatment of a disease selected from osteoporosis, Paget's disease, Chagas's disease, malaria, gingival diseases, hypercalaemia, metabolic bone disease, bone cancer |
| 07/23/2009 | US20090186898 Inhibitors of bruton's tyrosine kinase |
| 07/23/2009 | US20090186859 Diazeniumdiolated non-steroidal anti-inflammatory drugs, compositions thereof, and related methods |
| 07/23/2009 | US20090186831 Tetrahydrofuro(3,2-B) pyrrol-3-one derivatives as inhibitors of cysteine proteinases |
| 07/23/2009 | US20090186827 Process of inhibiting cell death in injured cartilage |
| 07/23/2009 | US20090186102 Herbal medicine for osteoporosis and related conditions |
| 07/23/2009 | US20090186062 Method of Repairing Meniscal Tears |
| 07/23/2009 | US20090186031 Compositions and methods for treating osteolytic disorders comprising mmp-14 binding proteins |
| 07/23/2009 | US20090186030 Antibodies that bind both bcma and taci |
| 07/23/2009 | US20090186010 Methods for the identification of ikkalfa function and other genes useful for treatment of inflammatory diseases |
| 07/23/2009 | US20090185979 Integrin Heterodimer and an Alpha Subunit Thereof |
| 07/23/2009 | CA2711763A1 Methods of treating bone-loss disorders using a gm-csf antagonist |
| 07/22/2009 | EP2081028A1 Use of a polypeptide to detect, prevent or treat a pathological state associated with a degenerative, neurological, autoimmune illness |
| 07/22/2009 | EP2080525A1 Remodeling and Glycoconjugation of Peptides |
| 07/22/2009 | EP2079739A2 Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
| 07/22/2009 | EP2079736A1 Substituted triazoles useful as axl inhibitors |
| 07/22/2009 | EP2079683A2 Di-fluoro containing compounds as cysteine protease inhibitors |
| 07/22/2009 | EP2079478A2 Materials and methods for treating and managing angiogenesis-mediated diseases |
| 07/22/2009 | EP1828166B1 Hydantoin derivatives useful as metalloproteinase inhibitors |
| 07/22/2009 | EP1605040B1 Monocyte-origin multipotent cell momc |
| 07/22/2009 | EP1531855A4 Treatment of bone disorders with skeletal anabolic drugs |
| 07/22/2009 | EP1492761B1 Amino acids with affinity for the alpha-2-delta-protein |
| 07/22/2009 | EP1392337B2 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating |
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
| 07/22/2009 | EP1263719B1 N-deacetylthiocolchine derivatives and pharmaceutical compositions containing them |
| 07/22/2009 | EP1220922B1 Method of identifying a compound with efficacy in the treatment of chronic inflammatory diseases |
| 07/22/2009 | EP1133517B1 INTRANUCLEAR TARGETED DELIVERY OF COMPOUNDS BY 70 kD HEAT SHOCK PROTEIN |
| 07/22/2009 | EP1115390B1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/22/2009 | CN101486682A N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/22/2009 | CN100516037C Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 07/22/2009 | CN100516024C Amino-propanol derivatives |
| 07/22/2009 | CN100515492C Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, purpose thereof and method of making same |
| 07/22/2009 | CN100515477C Chinese medicine decoction for treating prolapse of lumber intercertebtral disc |
| 07/22/2009 | CN100515422C Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 07/21/2009 | US7563824 Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 07/21/2009 | US7563800 Substituted pyrazolo[3,4-D]pyrimidines as p38 map kinase inhibitors |
| 07/21/2009 | US7563799 preferential enzyme inhibitors comprising fused pyrazolo derivatives, used for treating arthritis, Crohns disease, irritable bowel syndrome, adult respiratory distress syndrome, or chronic obstructive pulmonary disease |
| 07/21/2009 | US7563797 Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligands |
| 07/21/2009 | US7563793 Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents |
| 07/21/2009 | US7563790 Pyridazine derivatives |
| 07/21/2009 | US7563784 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 07/21/2009 | CA2470809C 6-amino-morphinan derivatives, method of manufacturing them and their application |
| 07/21/2009 | CA2406650C Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites |
| 07/21/2009 | CA2379972C Prodrug of an ice inhibitor |
| 07/16/2009 | WO2009089312A1 (e)-n-{3- [1-(8-fluoro-11h-10-oxa-1-aza-dibenzo [a,d] cycl0hepten-5ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid |
| 07/16/2009 | WO2009089093A1 Thyroid hormone receptor agonists |
| 07/16/2009 | WO2009089082A1 Trpa1 antagonists |
| 07/16/2009 | WO2009088997A1 Lactam inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/16/2009 | WO2009088063A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
| 07/16/2009 | WO2009087379A2 Tetrahydrofuro (3, 2 -b) pyrrol- 3 -one derivatives as inhibitors of cysteine proteinases |
| 07/16/2009 | WO2009087224A1 Pyrimidines as kinase inhibitors |
| 07/16/2009 | WO2009086952A2 Compositions for the treatment of degenerative articular diseases |
| 07/16/2009 | WO2009065946A3 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition |
| 07/16/2009 | WO2009050183A3 Imidazo [1, 2-a] pyridine derivatives useful as alk inhibitors |
| 07/16/2009 | WO2008132458A8 Compositions useful in the modulation of immune responses and the treatment or prevention of inflammatory responses and related methods |
| 07/16/2009 | WO2008090360A8 Methods |
| 07/16/2009 | US20090182047 Utilization of dialkylfumarates |
| 07/16/2009 | US20090182032 Companion animal compositions including lipoic acid and methods of use thereof |
| 07/16/2009 | US20090182027 Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 07/16/2009 | US20090181987 Inhibitors of brutons tyrosine kinase |
| 07/16/2009 | US20090181985 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 07/16/2009 | US20090181982 Substituted pyrroline kinase inhibitors |
| 07/16/2009 | US20090181972 Novel Inhibitors of Cysteine Proteases, the Pharmaceutical Compositions Thereof and their Therapeutic Applications |
| 07/16/2009 | US20090181962 Substituted thiophene compounds |
| 07/16/2009 | US20090181941 Pyrrolopyrimidines and Pyrrolopyridines |
| 07/16/2009 | US20090181897 Cxcr4 antagonist and use thereof |
| 07/16/2009 | US20090181108 Use of Bisphosphonates for Otosclerosis |
| 07/16/2009 | US20090181098 Hmg-Co-a Reductase Inhibitor Enhancement of Bone and Cartilage |
| 07/16/2009 | US20090181085 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate |
| 07/16/2009 | US20090181058 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 07/16/2009 | US20090181029 Methods for treating interleukin-6 related diseases |
| 07/16/2009 | US20090181020 Methods of Treating Bone-Loss Disorders Using a GM-CSF Antagonist |
| 07/16/2009 | US20090181019 Methods for the Treatment of Gout |
| 07/16/2009 | CA2711803A1 Pyridine derivatives |
| 07/16/2009 | CA2711637A1 Pyrimidines as kinase inhibitors |
| 07/16/2009 | CA2711612A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
| 07/16/2009 | CA2711408A1 Trpa1 antagonists |
| 07/16/2009 | CA2711288A1 Lactam inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/16/2009 | CA2710571A1 Osteogenic differentiation of bone marrow stem cells and mesenchymal stem cells using a combination of growth factors |
| 07/15/2009 | EP2078718A1 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 07/15/2009 | EP2078027A1 Cathepsin proteases inhibitors |
| 07/15/2009 | EP2078023A1 Tetrahydrofuro (3, 2-b) pyrrol-3-one derivatives as inhibitors of cysteine proteinases |
| 07/15/2009 | EP2078010A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/15/2009 | EP2077999A1 Hydroxamates as inhibitors of histone deacetylase |
| 07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 07/15/2009 | EP1141015B1 Insulin-like growth factor (igf) i mutant variants |
| 07/15/2009 | CN101481405A Somatostatin-dopamine chimeric analogs |
| 07/15/2009 | CN101481359A Cyclic protein tyrosine kinase inhibitors |
| 07/15/2009 | CN100513422C Parathyroid hormone-like polypeptides |
| 07/15/2009 | CN100513386C Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 07/15/2009 | CN100512837C Plaster for treating osteoarthropathy and preparing method |
| 07/15/2009 | CN100512809C Compounds and methods of treating transplant rejection |
| 07/15/2009 | CN100512807C Pharmaceutical for preventing and curing acute gout, tumor and hepatic/pulmonary fibrosis and preparation method thereof |
| 07/14/2009 | US7560591 Benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 07/14/2009 | US7560569 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity |
| 07/14/2009 | US7560558 quinoline pyridyl derivatives antagonist; antitumor agents; renal disease, hepatic fibrosis, cirrhosis, fibroid lung, scleroderma, wound healing, arthritis, congestive cardiac disease, ulcer, ocular disorder, cornea disorder, diabetic nephropathy |
| 07/14/2009 | US7560552 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 07/14/2009 | US7560551 Aurora kinase modulators and method of use |
| 07/14/2009 | US7560548 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |